International Conference on Infectious Diseases and Antimicrobial Resistance
(ICAMRSL2018) – 08th -11th August 2018 at the Hotel Taj Samudra, Colombo
Infectious Diseases caused by bacteria, viruses, fungi and parasites can lead to high mortality and morbidity. Antimicrobial Resistance (AMR) in these microorganisms lead to worse outcome as the effective treatment options will be limited with more side effects and treatment failures being associated with these second line treatment regimens. Though AMR is a global problem the highest impact is in Asia and Africa.
The National Strategic Plan for combating AMR (NSP) was launched in Sri Lanka in line with the Global Action Plan along with most other countries. For combating AMR NSP sets out the following 5 objectives:
- Improve awareness and understanding of antimicrobial resistance;
- Strengthen knowledge through surveillance and research;
- Reduce the incidence of infection;
- Optimize the use of antimicrobial agents; and
- Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Therefore the International Conference on Infectious Diseases and Antimicrobial Resistance (ICAMRSL2018) is organised in Colombo, Sri Lanka to facilitate these objectives, mainly the 1st and 2nd .
The objectives of the International Conference on Infectious Diseases and Antimicrobial Resistance (ICAMRSL2018) are:
- To raise awareness among clinicians including primary care physicians , policy makers and the public of the burden of AMR and on strategies for prevention and control of Infections and AMR in South Asia.
- To disseminate knowledge and skills pertaining to infectious diseases and AMR within the South Asian region
- To promote basic and applied research in infectious diseases and AMR.
- To promote collaboration among clinicians and researchers in the region to study the epidemiology, laboratory diagnosis, management and prevention and control of infections and AMR.